|
Task
Force 6: Training in Specialized Electrophysiology,
Cardiac Pacing and Arrhythmia Management
Mark E. Josephson, MD, FACC - Co-Chairman
James D. Maloney, MD, FACC - Co-Chairman
S. Serge Barold, MD, FACC
Nancy C. Flowers, MD, FACC
Nora F. Goldschlager, MD, FACC
David L. Hayes, MD, FACC
Eric Prystowsky, MD, FACC
Clinical cardiac electrophysiology and cardiac pacing
have matured significantly and are merging into a common
cardiac subspecialty discipline. Today, complex cardiac
arrhythmias are managed by cardiologists and cardiac
surgeons with special expertise in cardiac electrophysiology,
the use of implantable pacemakers and cardioverter-defibrillators
and the application of other interventional techniques
and treatments. Nonpharmacologic therapy also includes
electrophysiologic mapping and subsequent catheter or
surgical ablation as standard treatment for certain
tachyarrhythmias. Many new antiarrhythmic agents with
diverse mechanisms of action are often used therapeutically
alone or in conjunction with implantable multiprogrammable
arrhythmia control devices (pacemakers and implantable
cardioverter-defibrillators).
In 1986, Task Force VI, Training in Cardiac Pacing,
and Task Force VII, Training in Arrhythmias and Specialized
Electrophysiologic Studies and Interventions, were published
separately as a result of the Bethesda Conference 17
on adult cardiology training. The present task force
combines these two closely related disciplines to reflect
the current merging of science, art and practice of
clinical cardiac electrophysiology.
General
Standards and Environment
General
Standards, Facilities and Faculty
Three organizations, the American College of Cardiology
(ACC), American Heart Association (AHA) and The North
American Society of Pacing and Electrophysiology (NASPE),
have recently addressed training requirements and guidelines
for pacemaker implantation (1), guidelines
for use of implantable cardioverter-defibrillators in
cardiovascular practice (2), training
requirements for permanent pacemaker selection, implantation
and follow-up (3) and teaching objectives
for fellowship programs in clinical electrophysiology
(4,5). The training
recommendations for these three organizations are congruent
and address new technologies, faculty and facility requirements,
as well as practice standards.
It is strongly recommended that trainees who desire
admission to the American Board of Internal Medicine
(ABIM) examination for certification in Cardiovascular
Diseases and those who seek admission to the Clinical
Cardiac Electrophysiology (CCEP) Examination for certification
of added qualifications in clinical cardiac electrophysiology
be certain to obtain specific requirements from the
ABIM.
The cardiac arrhythmia aspects of a cardiology training
program should meet the published recommendations and
requirements regarding facilities and faculty (5).
Training must take place in an Accreditation Council
for Graduate Medical Education (ACGME) approved training
program. The intensity of training and the required
teaching resources may vary according to the level of
training provided. Facilities should be adequate to
ensure a safe, sterile and effective environment for
invasive electrophysiologic studies and implantation
of arrhythmia control devices. Faculty should include
specialists who are skilled in the medical and surgical
aspects of pacing and electrophysiology. The faculty
may be heterogeneous; however, at least one faculty
member must be board certified by the ABIM in clinical
cardiac electrophysiology (or its equivalent), and the
same or another faculty member must be recognized as
an expert in pacing for accrediting advanced levels
of training in each respective area.
Levels
of Training
Level 1
Within the cardiology core training program, level 1
should be at least 2 months of clinical rotation designed
for cardiology trainees to acquire knowledge and experience
in the diagnosis and management of bradyarrhythmias
and tachyarrhythmias. The cardiology trainee should
learn the indications for and limitations of electrophysiologic
studies, the appropriate use of pharmacologic and nonpharmacologic
therapeutic options and the proper and appropriate use
of antiarrhythmic agents, including drug interactions
and proarrhythmic potential. The level 1 trainee should
be exposed to noninvasive and invasive techniques related
to the diagnosis and management of patients with cardiac
arrhythmias that include ambulatory electrocardiographic
(ECG) monitoring, event recorders, exercise testing
for arrhythmia assessment, tilt table testing, signal-averaged
electrocardiography, invasive electrophysiologic testing
and implantation of cardiac arrhythmia control devices.
These requirements are in addition to the basic ECG
training as addressed in Task Force 2 and would require
an additional minimum of 2 months.
Electrocardiographic manifestations of arrhythmias should
be taught on a regular basis during formal ECG conferences.
Additional experience in heart rhythm disorders and
clinical correlations can be obtained from didactic
sessions and conferences; however, they must be supplemented
by rotation on an arrhythmia consultation service, during
which time the trainee should gain first-hand experience
as a consultant in arrhythmia management. Arrhythmias
associated with congenital heart disease, cardiac and
noncardiac surgical patients and the pre- and post-cardiac
transplantation patient are important components of
the arrhythmia core training. The level 1 cardiology
trainee experience should also include learning the
fundamentals of cardiac pacing; recognizing normal and
abnormal pacemaker function; and knowing indications
for temporary and permanent pacing, pacing modes and
the general approach to programming and surveillance
of pacemakers and implantable cardioverter-defibrillators.
The cardiology trainee should also be formally instructed
in and gain experience with 1) the insertion, management
and follow-up of temporary pacemakers (6);
2) measuring pacing and sensing thresholds and recording
electrograms for management of patients with temporary
pacemakers; and 3) indications and techniques for elective
and emergency cardioversions (7). Insertion
of a minimum of 10 temporary pacemakers and performance
of at least eight elective cardioversions is required.
These experiences can be obtained throughout the 24-month
clinical training period.
Level 2
All candidates for level 2 training must meet all training
requirements under level 1. Level 2 training consists
of a minimum of 6 months of training as a noninvasive
cardiac arrhythmia specialist with advanced competency
and proficiency in the diagnosis, treatment and longitudinal
care of patients with complex arrhythmias. Level 2 trainees
should meet all level 1 requirements and, in addition,
should obtain advanced training in normal and abnormal
cardiac electrophysiology and mechanisms of arrhythmias
and proficiency in the performance and interpretation
of noninvasive diagnostic procedures (ambulatory ECG
monitoring, event recording, telephone ECG transmission,
signal-averaged electrocardiography, tilt table testing,
heart rate variability and other tests of the autonomic
nervous system). Level 2 trainees should also acquire
knowledge of basic and clinical pharmacology of antiarrhythmic
agents and proficiency in their use. Of special importance
for the level 2 trainee is the acquisition of skills
and experience for managing inpatients and outpatients
with complex cardiac arrhythmias, including programming
and follow-up management of all types of bradycardia
pacing systems. The trainee is expected to function
as the primary programming operator who interrogates,
interprets, prescribes and reprograms in at least 100
patients. The trainee at this level must also acquire
advanced expertise in temporary pacing, transesophageal
atrial pacing, cardioversion, interpretation of invasive
electrophysiologic study data and complex arrhythmia
ECG interpretation. Although the level 2 trainee must
have significant exposure to invasive electrophysiology,
implantable cardioverter-defibrillators and the surgical
aspects of arrhythmia control device implantation, level
2 training will not qualify him or her to perform these
invasive procedures. The level 2 trainee has the option
of obtaining additional training in the surgical aspects
of pacemaker implantation or may choose the additional
training required for invasive cardiac electrophysiology,
or both, as described under level 3.
Level 3
This level of training is designed for the individual
who wishes to specialize in invasive diagnostic and
therapeutic cardiac electrophysiology (clinical cardiac
electrophysiology) (8). Requirements
of levels 1 and 2 must be fully met. Clinical cardiac
electrophysiology training will include a minimum of
4 years of training in clinical cardiology and electrophysiology.
Two years of training must be in clinical cardiology
and 2 years in electrophysiology, 1 year of which may
be research related, or 3 years of training in clinical
cardiology followed by a dedicated fourth year of training
in clinical cardiac electrophysiology. The appropriate
use, safe performance and judicious interpretation of
these complex procedures requires highly specialized
training and competence and cannot be completed in a
3-year training program. Further, an advanced knowledge
base in basic clinical cardiac electrophysiology and
pharmacology must provide a sound foundation for the
acquisition of technical abilities and cognitive skills
in management of patients with complex arrhythmias.
To complete level 3, in addition to level 1 and 2 requirements,
trainees should perform at least 100 electrophysiologic
procedures as the primary operator or as an assistant
involved with the acquisition and analysis of the data.
Electrophysiologic procedures should cover the total
spectrum of arrhythmias, both supraventricular and ventricular
tachyarrhythmias, as well as bradyarrhythmias. At least
50 of these procedures should be in patients with supraventricular
tachyarrhythmias. Expertise in catheter placement, programmed
electrical stimulation, endocardial mapping, catheter
ablation and interpretation of data must be assured
by the electrophysiology program director. The endocardial
mapping experience should include at least 15 cases
of left heart mapping using the retrograde aortic approach.
If expertise in transseptal catheterization is required,
training should be by an individual at the training
institution with expertise in the technique. Experience
with at least 10 transseptal catheterization procedures
is suggested as minimal required training. Participation
in a minimum of 50 catheter ablations, including ablation
and modification of the atrioventricular (AV) node,
AV accessory pathways, atrial flutter and atrial and
ventricular tachycardia is required. The trainee in
electrophysiology requires implantable cardioverter-defibrillator
experience that includes assisting with the primary
device implantation with electrophysiologic testing
at the time of implantation and with follow-up assessment.
This experience will include at least 50 device evaluations
(combined implantation and follow-up). Although the
level 3 trainee must have significant exposure to the
management and follow-up of implantable cardioverter-defibrillator
pacemaker implantation, he or she will not necessarily
be trained in the surgical aspects of these procedures
(Table 1).
Table
1: Cardia Arrhythmia and Electrophysiology Curriculum
Training Summary
| Level
|
Curriculum/Skills
|
Time
Requirement |
Device
Implantation |
| 1
|
Cardiac
arrhythmia and electrophysiology core |
2
mo (in addition to Task Force 2 training requirements)
|
No
|
| 2
|
Advanced
noninvasive |
6
mo |
Yes:
In addition to 6 mo of noninvasive emphasis, another
6 mo for a total of 12 mo is required for pacemaker
implantation training |
| 3
|
Clinical
invasive cardiac electrophysiology (meets the ABIM
CCEP Examination requirements) |
1
yr |
Yes:
A total of 1 yr beyond the 3-yr cardiology training
program is required. If surgical aspects of device
implantation are desired, a total of 12 mo within
the 4 yr will need to be devoted to these disciplines.
|
ABIM = American Board of Internal Medicine
CCEP = Clinical Cardiac Electrophysiology
Optional
Training in Device Implantation (Applicable to Level
2 or Level 3)
Level 2 and 3 trainees may choose to obtain additional
training in the surgical aspects of device implantation.
This device implantation training may be obtained concurrently
or sequentially with level 2 or level 3, respectively.
Training for the surgical implantation of permanent
bradycardia pacing systems can be obtained in both levels
2 and 3, whereas training in the surgical implantation
of implantable cardioverter-defibrillators can be obtained
in level 3 only. Training in the surgical aspects of
device implantation should not take place without the
supporting training of level 2 or level 3 training,
or both.
For those cardiology trainees who elect to obtain proficiency
in the surgical aspects of transvenous bradycardia device
implantation (pacemakers), previous or concurrent level
2 training is required. The pacemaker implantation training
must include developing expertise in permanent atrial
and ventricular lead placement, threshold testing and
programming of devices, principles of surgical asepsis,
surgical techniques of implantation and management of
implant-related complications. Individuals receiving
qualifying training in pacemaker implantation must participate
as the primary operator (but under direct supervision)
in at least 50 primary implantations of transvenous
pacemakers and 20 pacemaker system revisions or replacements.
At least half of the implantations should involve dual-chamber
pacemakers. The trainee must also participate in the
follow-up of at least 100 pacemaker patient visits and
acquire proficiency in advanced pacemaker electrocardiography,
interrogation and programming of complex pacemakers.
Level 2 training (6 months) with the option of training
in pacemaker implantation (6 months) requires a total
of 1 year of advanced training beyond the cardiology
core level 1. This may be obtained within a 3-year cardiology
program if 1 of the 3 years is dedicated to acquiring
pacemaker implantation skills plus related management
and follow-up skills. This training does not meet the
ABIM requirements for admission to the CCEP Examination.
The trainee pursuing a career in cardiac electrophysiology
as addressed under level 3 also has the option of obtaining
expertise in the surgical aspects of pacemaker or transvenous
implantable cardioverter-defibrillator implantation,
or both. The same amount of surgical experience with
bradycardia pacemaker implantation is required and may
be supplemented with surgical training for implantable
cardioverter-defibrillator implantation. If the level
3 trainee chooses this option, he or she must participate
as the primary implanter (under direct supervision)
in at least 20 implantable cardioverter-defibrillator
system implantations as well as the management and follow-up
skills addressed under level 3. The trainee must also
participate in the surgical replacement or revision
of at least 10 implantable cardioverter-defibrillator
systems and follow-up of at least 50 implantable cardioverter-defibrillator
patient visits. Level 3 training with the option of
pacemaker or implantable cardioverter-defibrillator
implantation, or both, requires a minimum of 1 year
of dedicated clinical cardiac electrophysiology and
device implantation training beyond the 3-year cardiology
program.
Evaluation,
Competency and Privileges
The program director should maintain adequate records
of each individual's training experiences and performances
of various procedures for appropriate documentation
for levels 1, 2 and 3. The trainees should also maintain
records of participation in the form of a logbook containing
clinical information, procedure performed and outcome
of procedures, including any complications encountered.
Competency examinations in electrocardiography and other
self-assessment programs are available through the ACC.
Training directors and trainees are encouraged to utilize
the resources. The ACGME has recently published the
essential components of a specialized program for training
in clinical cardiac electrophysiology. The ABIM provides
a special examination for additional certification in
clinical cardiac electrophysiology. Information concerning
the training requirements for admission to the examination
can be obtained from the ABIM; NASPE also has a written
examination of special competency in device therapy,
but it does not provide certification.
Subsequent privileges to perform invasive procedures
should be primarily granted on the basis of the technical
expertise acquired in the training program, the documented
training and the recommendations of the directors of
electrophysiology/pacing programs.
References
- Lehmann
MH, Saksena S. Implantable cardioverter defibrillators
in cardiovascular practice: report of the Policy Conference
of the North American Society of Pacing and Electrophysiology.
PACE 1991;14:969-79 and J Interv Cardiol
1991;4:211-20.
- Dreifus
LS, Fisch C, Griffin JC, Gillette PC, Mason JW, Parsonnet
V. Guidelines for implantation of cardiac pacemakers
and antiarrhythmia devices. A Report of the American
College of Cardiology/American Heart Association Task
Force on Assessment of Diagnostic and Therapeutic
Cardiovascular Procedures (Committee on Pacemaker
Implantation). J Am Coll Cardiol 1991; 18:1-13.
- Hayes
DL, Naccarelli GV, Furman S, et al. Report of the
NASPE Policy Conference training requirements for
permanent pacemaker selection, implantation, and follow-up.
North American Society of Pacing and Electrophysiology.
PACE Pacing Clin Electrophysiol 1994;17:6-12.
- Scheinman
M, Akhtar M, Brugada P, et al. Teaching objectives
for fellowship programs in clinical electrophysiology.
NASPE Policy Conference. PACE Pacing Clin Electrophysiol
1988;11:989-96.
- Scheinman
MM. Catheter ablation for cardiac arrhythmias, personnel,
and facilities. North American Society of Pacing and
Electrophysiology Ad Hoc Committee on Catheter Ablation.
PACE Pacing Clin Electrophysiol 1992;15:715-21.
- Francis
GS, Williams SV, Achord JL, et al. Clinical competence
in insertion of a temporary transvenous ventricular
pacemaker: a statement for physicians from the ACP/ACC/AHA
Task Force on Clinical Privileges in Cardiology. J
Am Coll Cardiol 1994;23: 1254-7.
- Yurchak
PM, Williams SV, Achord JL, et al. ACP/ACC/AHA Task
Force Statement: clinical competence in elective direct
current (DC) cardioversion. A statement for physicians
from the ACP/ACC/AHA Task Force on Clinical Privileges
in Cardiology. J Am Coll Cardiol 1993;22:336-9.
- Akhtar
M, Williams SV, Achord JL, et al. Clinical competence
in invasive cardiac electrophysiological studies.
A statement for physicians from the ACP/ACC/AHA Task
Force on Clinical Privileges in Cardiology. J Am
Coll Cardiol 1994;23:1258-61.
- Furman
S, Bilitch M. NASPExAM. PACE Pacing Clin Electrophysiol
1987;10:278-80.
Copyright © 1995 American College
of Cardiology
|